PRQR
ProQR Therapeutics BV
1.70$
+1.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 87.8% | 87.7% | 86.5% | 86.2% | 86.5% | 91.6% | 91.0% | 90.4% | 89.5% | 88.8% | 87.8% | 91.1% | |
| 84.9% | 86.3% | 69.2% | 66.9% | 83.7% | 89.0% | 87.3% | 87.1% | 86.0% | 82.0% | 81.9% | 87.7% | |
| 84.9% | 86.3% | 82.9% | 81.5% | 83.7% | 89.0% | 87.3% | 87.1% | 86.0% | 82.0% | 81.9% | 87.7% | |
| 2.2% | 0.9% | 2.5% | 3.9% | 1.2% | 1.2% | 1.8% | 1.8% | 2.0% | 4.5% | 2.7% | 1.4% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 67.4% | 70.0% | 71.9% | 72.2% | 76.6% | 47.3% | 48.0% | 51.3% | 54.1% | 56.2% | 62.0% | 40.5% | |
| 18.8% | 24.8% | 27.8% | 31.6% | 37.1% | 23.2% | 22.2% | 24.1% | 26.6% | 28.8% | 35.4% | 26.1% | |
| 2.7% | 1.2% | 3.5% | 3.9% | 4.0% | 2.7% | 2.9% | 3.3% | 3.7% | 3.9% | 4.7% | 3.4% | |
| 0.1% | 1.1% | 0.3% | 0.0% | 0.0% | 0.0% | 0.3% | 0.9% | 0.2% | 0.3% | 0.2% | 0.0% | |
| 1.9% | 2.8% | – | – | – | – | – | – | – | – | – | – | |
| 32.6% | 30.0% | 28.1% | 27.8% | 23.4% | 52.7% | 52.0% | 48.7% | 45.9% | 43.8% | 38.0% | 59.5% | |
| -278.6% | -290.7% | -329.5% | -347.8% | -391.2% | -254.3% | -287.6% | -325.6% | -368.9% | -414.6% | -483.6% | -365.0% | |
| 53.9% | 51.5% | 61.0% | 64.5% | 68.5% | 47.0% | 64.3% | 65.2% | 75.3% | 91.4% | 92.3% | 82.4% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.